Tirzepatide and semaglutide are both FDA-approved weekly injections for weight management and type 2 diabetes
10.1038/s41398-025-03372-w 304 MakkawiS.Camara-LemarroyC.MetzL
Fatigue is also reported by some individuals after the injection
Regular follow-ups allow us to address any concerns, celebrate milestones, and fine-tune your plan for long-term success
Secondly, significant weight loss and the resultant change in the inflammatory phenotype of obese adipose tissue would reduce the release into the circulation of key pro-fibrotic pro-inflammatory cytokines/adipokines such as TNF-, IL-6, leptin [31], visfatin and resistin, and increase levels of anti-fibrotic adipokines such as adiponectin [32]
Medically supervised semaglutide programs tailored to your goals In-depth guidance on storing compounded semaglutide and pens Support for both in-clinic and telehealth patients Convenient refill assistance and reminders Trusted by thousands across multiple U.S